Home Biosimilar Antibodies Transmembrane Transporters CD markers inhibitor Vadastuximab talirine For research use only.
Not for use in humans.

Vadastuximab talirine

Synonyms: SGN-CD33A, 33A

Vadastuximab talirine (SGN-CD33A, 33A) is an antibody-drug conjugate consisting of pyrrolobenzodiazepine dimers linked to a monoclonal antibody targeting CD33, which is expressed in the majority of acute myeloid leukemia (AML) patients.

Vadastuximab talirine

CAS No. 1436390-64-5

Purity & Quality Control

≥99

Choose Selective CD markers Inhibitors

Biological Activity

Description Vadastuximab talirine (SGN-CD33A, 33A) is an antibody-drug conjugate consisting of pyrrolobenzodiazepine dimers linked to a monoclonal antibody targeting CD33, which is expressed in the majority of acute myeloid leukemia (AML) patients.

Product Details

CAS No. 1436390-64-5
ADC antiody Vadastuximab
ADC cytotoxin PBD
Formulation 1xPBS
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Vadastuximab talirine | Vadastuximab talirine supplier | purchase Vadastuximab talirine | Vadastuximab talirine cost | Vadastuximab talirine manufacturer | order Vadastuximab talirine | Vadastuximab talirine distributor